Initiator Pharma A/S: Financial statements 2025
CVR: 37663808
Source: annual report 2025, Danish Business Authority
01/01/2025 – 31/12/2025
Initiator Pharma A/S (CVR 37663808) has filed annual accounts for 2025. In 2025, the company reported a gross profit of DKK -14,828,000 and a net result of DKK -13,687,000 compared with DKK -12,932,000 the year before. Equity in the 2025 report amounted to DKK 29,546,000. The solvency ratio was 87.5%. The company had 1 employee in the financial year.
- Gross Profit
- DKK -14,828,000
- Profit/Loss
- DKK -13,687,000
- Equity
- DKK 29,546,000
- Total Assets
- DKK 33,759,000
- Employees
- 1
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2025 | - | -14.8M | -13.7M | 29.5M | 1 |
| 2024 | - | -11.1M | -12.9M | 14.8M | 2 |
| 2023 | - | -23.4M | -22.9M | 11.2M | 2 |
| 2022 | - | -38.4M | -38.5M | 34M | 3 |
| 2021 | - | -22K | -21K | 35K | - |
Official annual report
How creditworthy is Initiator Pharma A/S?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2025
Initiator Pharma A/S has published its annual report for 2024. Gross profit came to DKK -11,073,000, and the net result was DKK -12,932,000.
As of May 23, 2025, Göran Albert Torstensson Ando has joined the board of directors of Initiator Pharma A/S.
As of May 23, 2025, Henrik Kristian Moltke has left the board of directors of Initiator Pharma A/S.
About Initiator Pharma A/S
Initiator Pharma A/S is a Danish company of the type Aktieselskab based in København N, founded in 2016. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of Claus Elsborg Olesen. The board consists of Gunnar Magnus Severus Modée Persson (chair), Annette Ingegerd Marie Colin, Claus Elsborg Olesen and Majken Christina Östberg Lloyd. The company is owned by Linc AB and Adrigo Asset Management. The company has 3 employees (2026). In 2025, the company reported a gross profit of DKK -14,828,000 and a net result of DKK -13,687,000 compared with DKK -12,932,000 the year before. Equity in the 2025 report amounted to DKK 29,546,000.
